Work

Ip12-31 the Efficacy and Safety of Disitamab Vedotin Combined With Immune Checkpoint Inhibitors in Patients With Metastatic Upper Tract Urothelial Carcinoma: a Multicenter Real-world Study

Year: 2025

Type: article

Source: The Journal of Urology

DOI: 10.1097/01.ju.0001109940.79528.1b.31

Authors: Cheoklong Ng, Taile Jing, Shicheng Yu, Jianjun Ye, Shun Zhang, Zhankui Jia, Qi Tang, Xiaoyi Hu, Minfeng Chen, Weiping Huang, Jitao Wu, Hai Bi, Zejun Yan, Haibo Shen, Wei Xiong, Zheng Liu, Jun Xiao, Tao Zhang, Xuedong Wei, Hailong Hu, Qing Yang, Yichu Yuan, Zhiyang Huang, Yige Bao, Guoqing Ding, Dan Xia, Wei Xue, Jiwei Huang

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409268458

FWCI:

Cites:

Cited by:

Related to: 10